Intensive Care Medicine

, Volume 29, Issue 7, pp 1202–1203 | Cite as

The importance of magnesium in critically ill patients: a role in mitigating neurological injury and in the prevention of vasospasms

  • Kees H. Polderman
  • Arthur R. H. van Zanten
  • Armand R. J. Girbes

Sir: We read with great interest the review on magnesium metabolism in critical illness by Noronha and Matuschak, which appeared in the June issue of Intensive Care Medicine [1]. We compliment the authors on their outstanding work, and hope that their review will contribute to an increased awareness of the importance of magnesium in critically ill patients. We would, however, like to make a number of additions to their otherwise thorough and comprehensive paper.

First, although Noronha and Matuschak briefly mention the possible neurological manifestations of hypomagnesaemia, they do not discuss the potentially important role of magnesium (Mg) in patients with various types of neurological injury. There is a large body of evidence (mainly from animal experiments) suggesting that Mg plays a key role in preventing additional brain damage following neurological injury [2, 3, 4, 5]. In experimentally induced brain injury, Mg depletion leads to significantly worse neurological outcome [2, 3]...


Therapeutic Hypothermia Neurological Injury Brain Damage Intensive Care Medicine Severe Head Injury 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Noronha JL, Matuschak GM (2002) Magnesium in critical illness: metabolism, assessment, and treatment. Intensive Care Med 28:667–679CrossRefGoogle Scholar
  2. 2.
    Bareyre FM, Saatman KE, Raghupathi R, McIntosh TK (2000) Postinjury treatment with magnesium chloride attenuates cortical damage after traumatic brain injury in rats. J Neurotrauma 17:1029–1039PubMedGoogle Scholar
  3. 3.
    Saatman KE, Bareyre FM, Grady MS, McIntosh TK (2001) Acute cytoskeletal alterations and cell death induced by experimental brain injury are attenuated by magnesium treatment and exacerbated by magnesium deficiency. J Neuropathol Exp Neurol 60:183–194PubMedGoogle Scholar
  4. 4.
    McIntosh TK, Vink R, Yamakami I, Faden AI (1989) Magnesium protects against neurological deficit after brain injury. Brain Res 482:252–260Google Scholar
  5. 5.
    Vink R, Cernak I (2000) Regulation of intracellular free magnesium in central nervous system injury. Front Biosci 5:D656–665PubMedGoogle Scholar
  6. 6.
    Polderman KH, Bloemers F, Peerdeman SM, Girbes ARJ (2000) Hypomagnesemia and hypophosphatemia at admission in patients with severe head injury. Crit Care Med 28:2022–2025Google Scholar
  7. 7.
    Polderman KH, Girbes ARJ, Peerdeman SM, Vandertop WP (2001) Hypothermia. J Neurosurg 94:853–855Google Scholar
  8. 8.
    Polderman KH, Peerdeman SM, Girbes ARJ (2001) Hypophosphatemia and hypomagnesemia induced by cooling in patients with severe head injury. J Neurosurg 94:697–705PubMedGoogle Scholar
  9. 9.
    Nadler JL, Rude RK (1995) Disorders of magnesium metabolism. Endocrinol Metab Clin North Am 24:623–641PubMedGoogle Scholar
  10. 10.
    Weisinger JR, Bellorín-Font E (1998) Magnesium and phosphorus. Lancet 352:391–396CrossRefPubMedGoogle Scholar
  11. 11.
    Pyne GJ, Cadoux-Hudson TA, Clark JF (2001) Magnesium protection against in vitro cerebral vasospasm after subarachnoid haemorrhage. Br J Neurosurg 15:409–415CrossRefPubMedGoogle Scholar
  12. 12.
    Teragawa H, Kato M, Yamagata T, Matsuura H, Kajiyama G (2000) The preventive effect of magnesium on coronary spasm in patients with vasospastic angina. Chest 118:1690–1695PubMedGoogle Scholar
  13. 13.
    Garcia LA, Dejong SC, Martin SM, Smith RS, Buettner GR, Kerber RE (1998) Magnesium reduces free radicals in an vivo coronary occlusion-reperfusion model. J Am Coll Cardiol 32:536–539CrossRefPubMedGoogle Scholar
  14. 14.
    Clermont G, Vergely C, Jazayeri S, Lahet JJ, Goudeau JJ, Lecour S, David M, Rochette L, Girard C (2002) Systemic free radical activation is a major event involved in myocardial oxidative stress related to cardiopulmonary bypass. Anesthesiology 96:80–87PubMedGoogle Scholar
  15. 15.
    van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359–1367PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2003

Authors and Affiliations

  • Kees H. Polderman
    • 1
  • Arthur R. H. van Zanten
    • 2
  • Armand R. J. Girbes
    • 1
  1. 1.Department of Intensive CareVU University Medical CenterAmsterdamThe Netherlands
  2. 2.Department of Intensive CareGelderse Vallei County HospitalEdeThe Netherlands

Personalised recommendations